We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Offers Advice for Sponsors of Individualized Gene Therapies
FDA Offers Advice for Sponsors of Individualized Gene Therapies
The FDA offered guidance for sponsors of individualized drugs developed for use against life-threatening genetic diseases in two draft guidances released yesterday.